69 , 73 When used in combination with other diabetes-specific HRQoL instruments, the SF-36 may help to provide insight in the impact of diabetes and treatments on patients quality of life In general use of the SF-36v2, the Users Manual 65 proposed the following minimally important differences (MID): a change of 2 points on the PCS, and 3 points on the MCS
Despite their benefits, GLP-1 drugs are not without risks
Once-weekly semaglutide aids weight loss by targeting hunger signals and blood sugar regulation
The watchdog also said these drugs must not be taken during pregnancy, while trying to get pregnant or while breastfeeding, as there was not enough safety data to know whether taking the medicine could cause harm to the baby
The landmark SELECT trial demonstrated that weekly semaglutide 2.4 mg reduces major cardiovascular events by 20% in people with obesity or overweight and established heart diseaseeven in those without diabetes.[1] This finding represents a paradigm shift in cardiovascular prevention, as it's the first time a weight-loss medication has been proven to directly reduce heart attacks, strokes, and cardiovascular deaths
Before you sign up, skim through independent forums and check how quickly issues are resolved
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
